Brilinta/Brilique

AstraZeneca on Brilinta SOCRATES trial in stroke: safety data is consistent with the known safety profile of Brilinta/Brilique

Missed primary efficacy endpoint; fewer events observed in the Brilinta arm but trend did not reach statistical significance Consistent safety…

8 years ago